Originally Posted by
Minerbarejet
I think this is where it all ties in with the R &D grants and funding from Callaghan Institute at roughly 1.5 mil per annum for the next three years, Skid. Plus whatever else gets chucked at it. I guess in a roundabout way PEB could be considered Otago University's Commercial Arm for getting the results of their research into the public arena. Payback will be in the form of dividends eventually I suppose which will then get put back into the pot as well.
In addition I dont think Otago University would be terribly chuffed about PEB being taken over either if it comes to that. I suppose the cxbladder developments could be sold on their own but they would still be in the market with colorectal, melanoma, gastric, all of which seem to be coming over the development horizon and into a medical centre near you.
Plus anything else they develop in the meantime in other cancer related fields and in that laboratory.
Another thing is that every time they do a test anywhere it is added to the databank of knowledge gained which in turn further validates the science.:)